224 related articles for article (PubMed ID: 9314368)
1. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy.
Nicholson AA; Ettles DF; Arnold A; Greenstone M; Dyet JF
J Vasc Interv Radiol; 1997; 8(5):781-8. PubMed ID: 9314368
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
3. Stent implantation in patients with superior vena cava syndrome.
Gross CM; Krämer J; Waigand J; Uhlich F; Schröder G; Thalhammer C; Dechend R; Gulba DC; Dietz R
AJR Am J Roentgenol; 1997 Aug; 169(2):429-32. PubMed ID: 9242747
[TBL] [Abstract][Full Text] [Related]
4. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
5. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
6. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
[TBL] [Abstract][Full Text] [Related]
8. Stenting in malignant obstruction of superior vena cava.
Shah R; Sabanathan S; Lowe RA; Mearns AJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):335-40. PubMed ID: 8751500
[TBL] [Abstract][Full Text] [Related]
9. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
[TBL] [Abstract][Full Text] [Related]
10. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
11. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
12. Stent insertion for malignant superior vena cava syndrome: effectiveness and long-term outcome.
Niu S; Xu YS; Cheng L; Cao C
Radiol Med; 2017 Aug; 122(8):633-638. PubMed ID: 28429206
[TBL] [Abstract][Full Text] [Related]
13. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction.
Han TM; Bondarev S; Keller EJ; Vogelzang RL; Resnick SA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):939-944. PubMed ID: 32414673
[TBL] [Abstract][Full Text] [Related]
15. Expandable Wallstent for the treatment of obstruction of the superior vena cava.
Watkinson AF; Hansell DM
Thorax; 1993 Sep; 48(9):915-20. PubMed ID: 7694384
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
17. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
18. Stenting in malignant vena caval obstruction.
Oudkerk M; Heystraten FM; Stoter G
Cancer; 1993 Jan; 71(1):142-6. PubMed ID: 8416711
[TBL] [Abstract][Full Text] [Related]
19. Treatment of superior and inferior vena cava syndromes of malignant cause with Wallstent catheter placed percutaneously.
Chacón López-Muñiz JI; García García L; Lanciego Pérez C; Cruz Mora MA; García Peris A; Martínez Martínez B; López Gómez L
Am J Clin Oncol; 1997 Jun; 20(3):293-7. PubMed ID: 9167757
[TBL] [Abstract][Full Text] [Related]
20. Intravascular stents in the management of superior vena cava syndrome.
Solomon N; Wholey MH; Jarmolowski CR
Cathet Cardiovasc Diagn; 1991 Aug; 23(4):245-52. PubMed ID: 1716179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
